Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSERIS 180 mg Switch Study in Schizophrenia
NCT03978832Phase 4Completed
- Sponsor
- Indivior
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perseris in schizophrenia, sponsored by Indivior. Started Jun 2019; status: completed.
02
Drugs
perseris
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03978832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03978832.